No matches
Pulmonology

How Can FeNO Measurement Improve Severe Asthma Management?

Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.
Miguel Lanz
MD, FAAAAI
Miguel Lanz

Learning objectives

  • Identify how type 2 inflammation leads to an increase in exhaled nitric oxide in severe asthma patients
  • Understand the clinical utility of FeNO as a diagnostic, prognostic, and predictive biomarker of severe asthma
Tags
biomarkersfenotype 2 inflammation
MAT-US-2410824 v1.0 -P Exp Date: 10/29/2026

About this expert

Allergy/Immunology
Pulmonology

Miguel Lanz

MD, FAAAAI

Lanz Allergy, Asthma & Immunology AAADRS Clinical Research Center | Coral Gables, Florida

See author’s profile
Miguel Lanz

Related resources

OCS Use in Severe Asthma Is Often Associated With Adverse Effects
Pulmonology
Infographic

OCS Use in Severe Asthma Is Often Associated With Adverse Effects

GINA Guidelines For Improved Outcomes With Effective Management of Pediatric Asthma
Pulmonology
interactivity

GINA Guidelines For Improved Outcomes With Effective Management of Pediatric Asthma

GOLD 2023 | Clinical Presentation of COPD and Disease Burden
Pulmonology
expert video

GOLD 2023 | Clinical Presentation of COPD and Disease Burden

Importance of Lung Function Assessment in Pediatric Asthma Patients
Pulmonology
videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

Adult Lung Function Static Infographic
Pulmonology
Infographic

Adult Lung Function Static Infographic

Asthma Remission: Moving Beyond Control
Pulmonology
interactivity

Asthma Remission: Moving Beyond Control

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?
Pulmonology
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Pulmonology
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
Pulmonology
expert video

Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care
Pulmonology
videoanimation

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care

Type 2 Inflammation Digital Assessment Tool
Pulmonology
interactivity

Type 2 Inflammation Digital Assessment Tool

Eosinophils as a Biomarker for Type 2 Asthma
Pulmonology
expert video

Eosinophils as a Biomarker for Type 2 Asthma

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?
Pulmonology
expert video

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden
Pulmonology
expert video

ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden

ERS 2024 | Unraveling the Role of Type 2 Inflammation in COPD
Pulmonology
expert video

ERS 2024 | Unraveling the Role of Type 2 Inflammation in COPD

ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe Asthma
Pulmonology
expert video

ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe Asthma

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation
Pulmonology
expert video

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

ERS 2024 | View From the Clinic: What Are the Clinical Consequences of Airway Remodeling?
Pulmonology
expert video

ERS 2024 | View From the Clinic: What Are the Clinical Consequences of Airway Remodeling?

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
Pulmonology
expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

ERS 2023 | Contextualizing Clinical Presentation of COPD Through Disease Pathology
Pulmonology
expert video

ERS 2023 | Contextualizing Clinical Presentation of COPD Through Disease Pathology

The Heterogeneity of Underlying Inflammation in Patients With COPD
Pulmonology
expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology
Pulmonology
expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD
Pulmonology
expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features
Pulmonology
expert video

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features

Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video
Pulmonology
videoanimation

Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video

What Are the Key Inflammatory Processes in Patients with COPD?
Pulmonology
expert video

What Are the Key Inflammatory Processes in Patients with COPD?

What Differentiates COPD Exacerbations From Asthma Exacerbations?
Pulmonology
expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

Burdens Experienced by Pediatric Asthma Patients and Their Caregivers
Pulmonology
expert video

Burdens Experienced by Pediatric Asthma Patients and Their Caregivers

Clinical Remission as a Goal in Asthma Clinical Practice
Pulmonology
expert video

Clinical Remission as a Goal in Asthma Clinical Practice

Concerns Surrounding OCS Side Effects in Patients With Severe Asthma
Pulmonology
expert video

Concerns Surrounding OCS Side Effects in Patients With Severe Asthma

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients
Pulmonology
expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

FeNO as a Biomarker for Type 2 Asthma
Pulmonology
expert video

FeNO as a Biomarker for Type 2 Asthma

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients
Pulmonology
Infographic

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

How Can FeNO Support the Management of Pediatric Asthma?
Pulmonology
expert video

How Can FeNO Support the Management of Pediatric Asthma?

How Can Poor Lung Function Impact Asthma Burden in Adult Patients?
Pulmonology
videoanimation

How Can Poor Lung Function Impact Asthma Burden in Adult Patients?

IgE as a Biomarker for Type 2 Asthma
Pulmonology
expert video

IgE as a Biomarker for Type 2 Asthma

Importance of Lung Function Assessment in Adult Asthma Patients
Pulmonology
videoanimation

Importance of Lung Function Assessment in Adult Asthma Patients

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
Pulmonology
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction
Pulmonology
Infographic

Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction

On-Treatment Clinical Remission in Asthma Patients Case Tool
Pulmonology
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pediatric Asthma Patient Case Tool: Ash
Pulmonology
interactivity

Pediatric Asthma Patient Case Tool: Ash

The Cycle of Inflammation in Adult Asthma
Pulmonology
interactivity

The Cycle of Inflammation in Adult Asthma

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma
Pulmonology
Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
Pulmonology
expert video

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients

What is the Role of FeNO as an Asthma Biomarker?
Pulmonology
expert video

What is the Role of FeNO as an Asthma Biomarker?

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond
Pulmonology
Podcast

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management
Pulmonology
expert video

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

ERS 2024 | Understanding the Complex Pathophysiology of COPD
Pulmonology
expert video

ERS 2024 | Understanding the Complex Pathophysiology of COPD

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region